ATE319442T1 - 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen - Google Patents

2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen

Info

Publication number
ATE319442T1
ATE319442T1 AT97920619T AT97920619T ATE319442T1 AT E319442 T1 ATE319442 T1 AT E319442T1 AT 97920619 T AT97920619 T AT 97920619T AT 97920619 T AT97920619 T AT 97920619T AT E319442 T1 ATE319442 T1 AT E319442T1
Authority
AT
Austria
Prior art keywords
treatment
dihydroxybenzylsulfone
derivatives
sexual disorders
disorders
Prior art date
Application number
AT97920619T
Other languages
English (en)
Inventor
Jose Esteve-Soler
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE319442T1 publication Critical patent/ATE319442T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97920619T 1996-04-03 1997-04-03 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen ATE319442T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604182A FR2747040B1 (fr) 1996-04-03 1996-04-03 Derives 2,5-dihydroxybenzenesulfoniques comme medicaments pour normaliser la fonction endotheliale et la fonction sexuelle, et traiter les troubles vasculaires d'origine diabetique ou endotheliale

Publications (1)

Publication Number Publication Date
ATE319442T1 true ATE319442T1 (de) 2006-03-15

Family

ID=9490865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920619T ATE319442T1 (de) 1996-04-03 1997-04-03 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen

Country Status (6)

Country Link
EP (1) EP1637133A3 (de)
AT (1) ATE319442T1 (de)
DK (1) DK0954298T3 (de)
ES (1) ES2127132B1 (de)
FR (1) FR2747040B1 (de)
PT (1) PT954298E (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436462A (en) * 1966-02-01 1969-04-01 Om Lab Sa Normalizing or reduction of the abnormal permeability of persons having capillar fragility with para-di-hydroxybenzene sulfonate
FR7465M (de) * 1968-06-26 1969-11-24
US3681503A (en) * 1970-04-17 1972-08-01 Om Lab Sa Method for combating disturbances of the lipid content of the blood
AR204506A1 (es) * 1972-05-17 1976-02-12 Esteve Labor Dr Procedimiento de preparacion de sales de acidos p-dihidroxibencenodisulfonicos

Also Published As

Publication number Publication date
ES2127132A1 (es) 1999-04-01
DK0954298T3 (da) 2006-06-12
ES2127132B1 (es) 1999-11-16
EP1637133A2 (de) 2006-03-22
FR2747040B1 (fr) 1998-06-26
FR2747040A1 (fr) 1997-10-10
PT954298E (pt) 2006-07-31
EP1637133A3 (de) 2007-07-11

Similar Documents

Publication Publication Date Title
ATE230757T1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE221054T1 (de) Substituierte oxazolyl-derivate zur behandlung von entzündungen
FI955315L (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
DE69726724D1 (de) Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE69206341D1 (de) Verfahren zur Behandlung von BCTMP/CTMP-Abwasser.
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
DE69831406D1 (de) Verwendung von thiazolidinedion-derivaten zur behandlung des polyzystischen ovarien syndroms und des schwangerschaftsdiabetes
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
ATE218857T1 (de) Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen
DE69210654D1 (de) Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
PT954298E (pt) Derivados 2,5-di-hidroxibenzenossulfonicos para o tratamento da disfuncao sexual
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69720064D1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0954298

Country of ref document: EP

REN Ceased due to non-payment of the annual fee